Padmashri Ponnaluri

Array ( [id] => 18598409 [patent_doc_number] => 20230273208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => SOLUBLE TREM-1 AS A MARKER OF SEVERITY OR COMPLICATIONS FOR A SUBJECT SUFFERING FROM A CORONAVIRUS INFECTION [patent_app_type] => utility [patent_app_number] => 18/007849 [patent_app_country] => US [patent_app_date] => 2021-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37331 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20270072 [patent_doc_number] => RE050635 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-10-14 [patent_title] => Neural regenerating cells with alterations in DNA methylation [patent_app_type] => reissue [patent_app_number] => 17/339167 [patent_app_country] => US [patent_app_date] => 2021-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3514 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17339167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20755749 [patent_doc_number] => RE050908 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2026-06-09 [patent_title] => Vaccine compositions and methods for restoring NKG2D pathway function against cancers [patent_app_type] => reissue [patent_app_number] => 17/314828 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8576 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17936317 [patent_doc_number] => RE049251 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-10-18 [patent_title] => Depot systems comprising glatiramer or pharmacologically acceptable salt thereof [patent_app_type] => reissue [patent_app_number] => 17/213352 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11272 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17213352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19395637 [patent_doc_number] => RE050096 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-08-27 [patent_title] => Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells [patent_app_type] => reissue [patent_app_number] => 17/179720 [patent_app_country] => US [patent_app_date] => 2021-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 79 [patent_no_of_words] => 16862 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18502989 [patent_doc_number] => RE049583 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-07-18 [patent_title] => Inducible expression systems [patent_app_type] => reissue [patent_app_number] => 17/166090 [patent_app_country] => US [patent_app_date] => 2021-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 26 [patent_no_of_words] => 26268 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19649393 [patent_doc_number] => RE050240 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-12-24 [patent_title] => Anti-human transferrin receptor antibody capable of penetrating blood-brain barrier [patent_app_type] => reissue [patent_app_number] => 17/161718 [patent_app_country] => US [patent_app_date] => 2021-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 91104 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17161718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18715773 [patent_doc_number] => RE049708 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-10-24 [patent_title] => Nucleic acid molecules encoding indoleamine 2,3-dioxygenase-2 [patent_app_type] => reissue [patent_app_number] => 17/145002 [patent_app_country] => US [patent_app_date] => 2021-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 123 [patent_figures_cnt] => 126 [patent_no_of_words] => 18527 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16824284 [patent_doc_number] => 20210139577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS [patent_app_type] => utility [patent_app_number] => 17/115326 [patent_app_country] => US [patent_app_date] => 2020-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19368 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17115326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18214574 [patent_doc_number] => RE049431 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-02-28 [patent_title] => RNA interference agents for GST-PI gene modulation [patent_app_type] => reissue [patent_app_number] => 16/990860 [patent_app_country] => US [patent_app_date] => 2020-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14850 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18588501 [patent_doc_number] => RE049625 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-08-29 [patent_title] => Nanoscale process to generate reagents selective for individual protein variants [patent_app_type] => reissue [patent_app_number] => 16/845761 [patent_app_country] => US [patent_app_date] => 2020-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 8 [patent_no_of_words] => 10874 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16845761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18313631 [patent_doc_number] => RE049495 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-04-18 [patent_title] => Binding polypeptides having a mutated scaffold [patent_app_type] => reissue [patent_app_number] => 16/840882 [patent_app_country] => US [patent_app_date] => 2020-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15018 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18792030 [patent_doc_number] => RE049736 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-11-28 [patent_title] => Pegylated L-asparaginase [patent_app_type] => reissue [patent_app_number] => 16/822764 [patent_app_country] => US [patent_app_date] => 2020-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15329 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16822764 [rel_patent_id] =>[rel_patent_doc_number] =>)